Document Detail

Endoprosthetic management of refractory ileocolonic anastomotic strictures after resection for Crohn's disease: Report of nine-year follow-up and review of the literature.
MedLine Citation:
PMID:  21542067     Owner:  NLM     Status:  Publisher    
BACKGROUND: The role of endoluminal stenting in benign obstruction, especially for Crohn's disease (CD), is controversial, with limited data and widely disparate outcomes. The purpose of this study was to determine the long-term efficacy and safety of this technology in the treatment of fibrostenotic CD and to review the existing literature on this topic. METHODS: We undertook a retrospective review of all patients undergoing endoluminal stenting for CD strictures at our institution from 2001 to 2010. Outcome measures included technical success, clinical improvement, duration of stent and luminal patency, and need for re-intervention. RESULTS: Five patients underwent this procedure with a 100% rate of technical and an 80% rate of clinical success. Mean follow-up was 28 months (range 3 weeks to 109 months) and mean long-term luminal patency was 34.8 months (range 4.5-109 months). There was one complication involving reobstruction which required surgical intervention and no mortalities. CONCLUSIONS: Endoluminal stenting of CD strictures is a safe and effective alternative to surgery which can provide lasting benefit in select patients. Further studies are necessary to clarify the full impact of this technology on long-term management of this complex disease. (Inflamm Bowel Dis 2011;).
Rebecca A Levine; Harry Wasvary; Omar Kadro
Related Documents :
21361827 - Shockwave lithotripsy in patients with horseshoe kidney: determinants of success.
21335007 - Iron levels in hepatocytes and portal tract cells predict progression and outcomes of p...
21131847 - Use of acellular dermal replacement in reconstruction of nonhealing lower extremity wou...
9069217 - Colorectal resection and anal anastomosis with an intraluminal stapler in hirschsprung'...
18426627 - Preoperatively administered ramosetron oral disintegrating tablets for preventing nause...
16733647 - Changes in surgical therapy for crohn's disease over 33 years: a prospective longitudin...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-5-3
Journal Detail:
Title:  Inflammatory bowel diseases     Volume:  -     ISSN:  1536-4844     ISO Abbreviation:  -     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-5-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9508162     Medline TA:  Inflamm Bowel Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.
Department of Colon & Rectal Surgery, William Beaumont Hospital, Royal Oak, Michigan; Department of Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pseudoexon exclusion by antisense therapy in 6-pyruvoyl-tetrahydropterin synthase deficiency.
Next Document:  Accessing the hidden majority of marine natural products through metagenomics.